
Hepato-Pancreato-Biliary Surgeon

No OPD information available
Colorectal Cancer
Dehydration
Diarrhea
Hepato-Pancreato-Biliary Surgery
Liver Cancer
Neuroendocrine Tumor
Pancreatic Islet Cell Tumor
Guy A. Van Hazel is a male medical professional who helps patients with different health issues like colorectal cancer, dehydration, diarrhea, liver cancer, and more. He is skilled in Hepato-Pancreato-Biliary Surgery and treating neuroendocrine tumors and pancreatic islet cell tumors.
Guy A. Van Hazel cares for patients by using his special skills and treatments to improve their health. He communicates with patients in a friendly and clear way, which helps them trust him and feel comfortable during their treatment.
To stay updated with the latest medical knowledge, Guy A. Van Hazel regularly reads research articles and attends medical conferences. This helps him provide the best care for his patients and stay informed about new treatments and technologies.
Guy A. Van Hazel works well with his colleagues and other medical professionals. He values teamwork and collaboration to ensure that patients receive comprehensive care and support throughout their treatment journey.
Through his work, Guy A. Van Hazel has positively impacted many patients' lives by providing effective treatments and compassionate care. His dedication to improving patient outcomes and quality of life has earned him the trust and gratitude of those he has helped.
One of Guy A. Van Hazel's notable publications is "Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer" in the ANZ journal of surgery. He is also involved in a clinical trial called "Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers," which aims to find better treatments for these types of cancer.
Overall, Guy A. Van Hazel's commitment to patient care, continuous learning, collaboration with colleagues, and impactful work in the medical field make him a respected and trusted healthcare professional.
Enrollment Status: Active not recruiting
Published: February 02, 2024
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
